Krsnaa Diagnostics Board Meeting on Aug 13 to Approve Q1 FY27 Results

Krsnaa Diagnostics Ltd has announced a Board of Directors meeting scheduled for August 13, 2026. The primary agenda items include the consideration and approval of the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Additionally, the board will evaluate a proposal for fundraising through the issuance of various securities, potentially including equity shares and warrants, via preferential issue or other permissible modes. The trading window for company securities will remain closed until August 15, 2026.